Meet Acumetis at AMCP Nexus 2026!
Connect with our Global Value and Access team
October 26 – 29, 2026 | San Diego, California
Acumetis will be attending AMCP Nexus 2026. Our Global Value & Access (GVA) team will be on-site to connect with industry leaders and discuss the evolving evidence, value, and access challenges facing life sciences organizations across global markets.
Meet us at our booth #413.
Navigating evolving payer and access expectations
As evidence requirements, escalating pricing and reimbursement scrutiny, complex regulatory hurdles, diverse health technology, and payer expectations evolve, life sciences organizations need to demonstrate value in ways that are relevant to the stakeholders making coverage and access decisions.
Acumetis connects evidence generation, HEOR, value communications, pricing, and market access strategy to help teams anticipate payer needs, strengthen the value proposition, identify the white spaces, and make more informed access decisions throughout the product lifecycle.
Key areas of focus
At AMCP Nexus 2026, our discussions will be focused on:
- Payer insights & strategy — Building brand- and category-specific insights to inform payer strategy and access planning
- Value communications — Tailoring value messaging to payer priorities, evidence needs, and channel strategies
- Payer & channel marketing — Developing compelling strategies and communications that strengthen brand positioning in competitive markets
- Evidence & HEOR — Generating and translating evidence to demonstrate value and support payer decision-making
- Pricing & reimbursement — Navigating evolving pricing, reimbursement, and policy dynamics to support market access
- Patient access & affordability — Developing strategies that address access barriers and support pathways to therapy
- Market access planning — Connecting evidence, payer insights, pricing, and channel considerations across the product lifecycle
Where to Find Us
Visit the Acumetis Global Value & Access team at Booth #413 during AMCP Nexus 2026. Connect with our experts to discuss your priorities across market access strategy, evidence generation, HEOR, value communications, and pricing and reimbursement.
About Acumetis
Acumetis partners with life sciences organizations to navigate complex strategic, scientific, and commercial challenges across the product lifecycle. We bring together medical, access, commercial, insights, and patient support strategy into a coordinated path forward, building the knowledge and clarity that strengthen decision-making.
Our work spans Medical Affairs, Market Access, and Commercial Strategy, supporting teams in connecting evidence, engagement, and execution to drive meaningful outcomes. At the core of our approach is a focus on reframing challenges, bringing strategic clarity, and creating critical connections that enable progress in practice.
Who You’ll Meet
James Convery – Principal, Global Value and Access
James Convery is a highly experienced commercial strategist and market access leader with +25 years of experience supporting pharma, biotech, medical device and healthcare organizations across a broad range of TA’s. His expertise spans market access, pricing and reimbursement, brand and channel strategy, product launch planning, stakeholder engagement, value proposition development, market research and patient journey optimization. He has extensive experience supporting clients across the full product lifecycle, from early pipeline strategy and evidence generation through to launch, access optimization and commercial growth. He has successfully developed and implemented market access and value strategies, budget impact and economic models, pricing and contracting approaches, and customer engagement programs.
Collin Wolf- Director of Client Success
Collin Wolf is a Director of Client Success at Acumetis, where he draws on his background as a PharmD and digital health entrepreneur to lead high-impact client engagements. Collin develops strategic, industry-leading offerings and building trusted partnerships with pharmaceutical and biotech clients. His work spans multiple functional areas—including patient services, launch, market access, and medical functions—bringing an execution-focused approach that aligns cross-functional stakeholders and accelerates performance. He has deep experience supporting specialty, rare disease, and gene therapies, guiding clients through product launches, access optimization, and field deployment strategies.
Jasmeen Kaur– Manager
Jasmeen Kaur is a manager at Acumetis with extensive experience in real-world evidence, economic modelling, pharmacoepidemiology studies, and data analytics with a focus on claims, EHR, and registry data. She has worked alongside Takeda’s gastrointestinal and neurology teams and contributed to two significant product launches.
Karl Freemyer– SVP, Business Development GVA & EU
Karl leads strategy and implementation, helping pharma and biotech clients address evolving market access challenges. With over 15 years of experience, he brings deep expertise in BD and operations in HEOR and market access consulting, commercial experience at multinational pharmaceutical and laboratory diagnostics companies, and market research expertise in nutrition, functional foods, and beverages. He held roles at AstraZeneca, LabCorp, and DSM Nutritional Products, gaining hands-on experience across development and commercialization. In consulting, Karl has led strategic initiatives at Covance and Genesis Research to support HEOR and access optimization.
Visit our related resources